|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1999-9-20
|
|
pubmed:abstractText |
To evaluate whether ketorolac ophthalmic drops prescribed four times a day can be associated with improved visual acuity and prompt resolution of edema for patients with pseudophakic cystoid macular edema identified more than 24 months after cataract surgery.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1656-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10485530-Aged,
pubmed-meshheading:10485530-Aged, 80 and over,
pubmed-meshheading:10485530-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:10485530-Cataract Extraction,
pubmed-meshheading:10485530-Chronic Disease,
pubmed-meshheading:10485530-Female,
pubmed-meshheading:10485530-Fluorescein Angiography,
pubmed-meshheading:10485530-Fundus Oculi,
pubmed-meshheading:10485530-Humans,
pubmed-meshheading:10485530-Ketorolac,
pubmed-meshheading:10485530-Macular Edema,
pubmed-meshheading:10485530-Male,
pubmed-meshheading:10485530-Ophthalmic Solutions,
pubmed-meshheading:10485530-Prospective Studies,
pubmed-meshheading:10485530-Pseudophakia,
pubmed-meshheading:10485530-Time Factors,
pubmed-meshheading:10485530-Tolmetin,
pubmed-meshheading:10485530-Visual Acuity
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
|
|
pubmed:affiliation |
Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
